DJIA 17,356.87 288.00 1.69%
NASDAQ 4,644.31 96.48 2.12%
S&P 500 2,012.89 40.15 2.04%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

57.63 0.83 (1.46%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $57.63 1.46%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $57.05
Previous Close $56.80
Daily Range $56.56 - $57.80
52-Week Range $47.61 - $62.20
Market Cap $164.3B
P/E Ratio 30.87
Dividend (Yield) $1.80 (3.2%)
Ex-Dividend Date
Dividend Pay Date
12/11/14
01/08/15
Volume 12,669,762
Average Daily Volume 10,073,719
Current FY EPS $3.49

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary

The 3 Most Exceptional CEOs of 2014

These three CEOs delivered big gains for their shareholders in 2014. Find out what makes them so special.

Roche Hopes For Melanoma Therapy Approval

Pfizer’s Acquisition Strategy: Will Pfizer Still Go For A Big Acquisition? (Part 1 of 2)

NewLink Genetics: Examining Likelihood Of Success In The IMPRESS Trial

Cubist Pharmaceuticals: An Extraordinary Arbitrage Opportunity

Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog

Quick Analysis Of Merck's Acquisition Of Cubist

Pfizer Moving Into Gene Therapy Is A Welcome Move

Assessing Gilead's Reality-Perception Gap

Twitter's Favorite Biotech and Pharma Stocks

Consensus? We don't need no stinking consensus!

See More MRK News...

MRK's Top Competitors

MRK $57.63 (1.46%)
Current stock: MRK
JNJ $104.07 (1.27%)
Current stock: JNJ
NVS $92.29 (0.70%)
Current stock: NVS
PFE $31.12 (1.47%)
Current stock: PFE